June 2, 2020 / 11:12 AM / a month ago

BRIEF-MindMed Expands Phase 2 Trial Of Microdosing LSD For Adult ADHD

June 2 (Reuters) - Mind Medicine (MindMed) Inc:

* MINDMED'S MICRODOSING DIVISION FURTHER EXPANDS PHASE 2 CLINICAL TRIAL OF MICRODOSING LSD FOR ADULT ADHD

* MIND MEDICINE - TO ADD ADDITIONAL CLINICAL TRIAL SITE AT UNIVERSITY HOSPITAL BASEL IN SWITZERLAND FOR PHASE 2A TRIAL OF MICRODOSING LSD Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below